Compare CNXU & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNXU | UPXI |
|---|---|---|
| Founded | 2022 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.8M | 84.6M |
| IPO Year | 2025 | 2021 |
| Metric | CNXU | UPXI |
|---|---|---|
| Price | $2.12 | $0.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 310.9K | ★ 1.4M |
| Earning Date | 02-03-2027 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $24,998,028.00 |
| Revenue This Year | N/A | $6.81 |
| Revenue Next Year | N/A | $63.30 |
| P/E Ratio | ★ N/A | $0.94 |
| Revenue Growth | N/A | ★ 58.10 |
| 52 Week Low | $1.93 | $0.54 |
| 52 Week High | $13.66 | $3.12 |
| Indicator | CNXU | UPXI |
|---|---|---|
| Relative Strength Index (RSI) | 32.07 | 34.34 |
| Support Level | N/A | $0.54 |
| Resistance Level | $4.36 | $0.89 |
| Average True Range (ATR) | 0.28 | 0.07 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 15.89 | 15.64 |
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. The company is in the cryptocurrency industry and the management of cash assets through a cryptocurrency portfolio, principally focused in Solana tokens and generating a yield from the treasury, principally through staking of those tokens. Geographically, the company generates the majority of its revenue from the United States. The firm generates the majority of its revenue from the Digital Asset revenue.